Trial intelligence / Profile preview

HAPPIEST: Bupivacaine-Impregnated Mesh in Hernia Repair

NCT03035617Unknown

Sponsor
Aga Khan University
Start
Nov 2015
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Aga Khan University. Primary endpoint: Post-Operative Pain assessed by Visual Analogue Scale (VAS) at 24 hours. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03035617.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03035617.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call